{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T10:41:08Z","timestamp":1766486468873,"version":"3.37.3"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004166","name":"Medical University of Warsaw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ijbiomac.2024.131405","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T15:31:45Z","timestamp":1712244705000},"page":"131405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P2","title":["Binding mechanism of pentamidine derivatives with human serum acute phase protein \u03b11-acid glycoprotein"],"prefix":"10.1016","volume":"266","author":[{"given":"Teresa","family":"\u017bo\u0142ek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orsolya","family":"D\u00f6m\u00f6t\u00f6r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy","family":"\u017babi\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.ijbiomac.2024.131405_bb0005","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.2174\/1381612821666150304161201","article-title":"Understanding the interaction between human serum albumin and anti-bacterial\/ anti-cancer compounds","volume":"21","author":"Rehman","year":"2015","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131405_bb0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1081\/DMR-100104402","article-title":"Human alpha-1-glycoprotein and its interactions with drugs","volume":"33","author":"Israili","year":"2001","journal-title":"Drug Metab. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131405_bb0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00007691-200402000-00009","article-title":"The binding of selected therapeutic drugs to human serum alpha-1 acid glycoprotein and to human serum albumin in vitro","volume":"26","author":"Bailey","year":"2004","journal-title":"Ther. Drug Monit."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131405_bb0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11095-018-2551-x","article-title":"Pharmacokinetic and pharmacodynamic considerations for drugs binding to alpha-1-acid glycoprotein","volume":"36","author":"Smith","year":"2018","journal-title":"Pharm. Res."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2024.131405_bb0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0167-4838(00)00153-9","article-title":"Alpha-1-acid glycoprotein","volume":"1482","author":"Fournier","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131405_bb0030","first-page":"226","article-title":"Effect of alpha-1-acid glycoprotein binding on pharmacokinetics and pharmacodynamics","volume":"14","author":"Huang","year":"2013","journal-title":"Curr. Drug Metab."},{"issue":"2\u20133","key":"10.1016\/j.ijbiomac.2024.131405_bb0035","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0009-8981(91)90312-Z","article-title":"Variations in relative concentrations of variants of human alpha 1-acid glycoprotein after acute-phase conditions","volume":"203","author":"Eap","year":"1991","journal-title":"Clin. Chim. Acta"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.131405_bb0040","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2133\/dmpk.20.309","article-title":"A molecular functional study on the interactions of drugs with plasma proteins","volume":"20","author":"Otagiri","year":"2005","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"15","key":"10.1016\/j.ijbiomac.2024.131405_bb0045","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1016\/j.carres.2006.07.012","article-title":"Progesterone binding to the tryptophan residues of human alpha1-acid glycoprotein","volume":"341","author":"Albani","year":"2006","journal-title":"Carbohydr. Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131405_bb0050","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/(SICI)1520-636X(1997)9:3<291::AID-CHIR15>3.0.CO;2-I","article-title":"Effect of sialic acid residues of human alpha 1-acid glycoprotein on stereoselectivity in basic drug-protein binding","volume":"9","author":"Shiono","year":"1997","journal-title":"Chirality"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131405_bb0055","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.bcp.2012.05.004","article-title":"Structure-activity relationships for the binding of polymyxins with human alpha-1-acid glycoprotein","volume":"84","author":"Azad","year":"2012","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131405_bb0060","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1021\/acs.jcim.8b00558","article-title":"Comparative binding analysis of N-acetylneuraminic acid in bovine serum albumin and human alpha-1 acid glycoprotein","volume":"59","author":"Karthikeyan","year":"2019","journal-title":"J. Chem. Inf. Model."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131405_bb0065","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s40268-017-0193-9","article-title":"Lipophilicity influences drug binding to alpha1-acid glycoprotein F1\/S variants but not to the a variant","volume":"17","author":"Hanada","year":"2017","journal-title":"Drugs R D"},{"key":"10.1016\/j.ijbiomac.2024.131405_bb0070","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jpba.2016.12.001","article-title":"Interaction of anticancer drug clofarabine with human serum albumin and human alpha-1 acid glycoprotein. Spectroscopic and molecular docking approach","volume":"135","author":"Ajmal","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.131405_bb0075","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1080\/07391102.2014.947326","article-title":"Cytotoxicity and comparative binding mechanism of piperine with human serum albumin and alpha-1-acid glycoprotein","volume":"33","author":"Yeggoni","year":"2015","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.131405_bb0080","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1017\/S003118201300022X","article-title":"Genetic dissection of drug resistance in trypanosomes","volume":"140","author":"Alsford","year":"2013","journal-title":"Parasitology"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.131405_bb0085","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1471-4922(03)00069-2","article-title":"Pentamidine uptake and resistance in pathogenic protozoa: past, present and future","volume":"19","author":"Bray","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijbiomac.2024.131405_bb0090","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.2147\/IJN.S140363","article-title":"Nanostructured delivery systems with improved leishmanicidal activity: a critical review","volume":"12","author":"Bruni","year":"2017","journal-title":"Int. J. Nanomedicine"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131405_bb0095","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/petr.12441","article-title":"Intravenous pentamidine for Pneumocystis carinii\/jiroveci pneumonia prophylaxis in pediatric transplant patients","volume":"19","author":"Clark","year":"2015","journal-title":"Pediatr. Transplant."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131405_bb0100","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12718","article-title":"Pentamidine inhibits prostate cancer progression via selectively inducing mitochondrial DNA depletion and dysfunction","volume":"53","author":"Liu","year":"2020","journal-title":"Cell Prolif."},{"issue":"9","key":"10.1016\/j.ijbiomac.2024.131405_bb0105","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1128\/AAC.34.9.1795","article-title":"Antistaphylococcal activity of pentamidine","volume":"34","author":"Libman","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"issue":"13","key":"10.1016\/j.ijbiomac.2024.131405_bb0110","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1016\/j.bmcl.2014.04.075","article-title":"In vitro screening of pentamidine analogs against bacterial and fungal strains","volume":"24","author":"Maciejewska","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"31","key":"10.1016\/j.ijbiomac.2024.131405_bb0115","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.1021\/bi00146a011","article-title":"Crystal structure of a pentamidine-oligonucleotide complex: implications for DNA-binding properties","volume":"31","author":"Edwards","year":"1992","journal-title":"Biochemistry"},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.131405_bb0120","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1093\/nar\/gkm1180","article-title":"Pentamidine binds to tRNA through non-specific hydrophobic interactions and inhibits aminoacylation and translation","volume":"36","author":"Sun","year":"2008","journal-title":"Nucleic Acids Res."},{"issue":"32","key":"10.1016\/j.ijbiomac.2024.131405_bb0125","doi-asserted-by":"crossref","first-page":"E7587","DOI":"10.1073\/pnas.1803975115","article-title":"Liquid crystalline bacterial outer membranes are critical for antibiotic susceptibility","volume":"115","author":"Paracini","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"14","key":"10.1016\/j.ijbiomac.2024.131405_bb0130","first-page":"1255","article-title":"Pentamidine is an inhibitor of PRL phosphatases with anticancer activity","volume":"1","author":"Pathak","year":"2002","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131405_bb0135","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/clpt.1986.38","article-title":"Pentamidine-induced hypoglycemia in patients with the acquired immune deficiency syndrome","volume":"39","author":"Stahl-Bayliss","year":"1986","journal-title":"Clin. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.131405_bb0140","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1128\/AAC.00126-06","article-title":"In vitro selection and in vivo efficacy of piperazine- and alkanediamide-linked bisbenzamidines against Pneumocystis pneumonia in mice","volume":"50","author":"Cushion","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131405_bb0145","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1128\/AAC.42.3.666","article-title":"Anti-pneumocystis activities of aromatic diamidoxime prodrugs","volume":"42","author":"Hall","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.131405_bb0150","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/j.ejmech.2011.04.001","article-title":"Novel pentamidine derivatives: synthesis, anti-tumor properties and polynucleotide-binding activities","volume":"46","author":"Jarak","year":"2011","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2024.131405_bb0155","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.bjp.0707354","article-title":"Human African trypanosomiasis: pharmacological re-engagement with a neglected disease","volume":"152","author":"Barrett","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2024.131405_bb0160","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0960-894X(97)00229-1","article-title":"Cytotoxicity of bis(phenylamidinium)furan alkyl derivatives in human tumour cell lines: relation to DNA minor groove binding","volume":"7","author":"Neidle","year":"1997","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"24","key":"10.1016\/j.ijbiomac.2024.131405_bb0165","first-page":"7219","article-title":"Distribution of furamidine analogues in tumor cells: targeting of the nucleus or mitochondria depending on the amidine substitution","volume":"62","author":"Lansiaux","year":"2002","journal-title":"Cancer Res."},{"issue":"50","key":"10.1016\/j.ijbiomac.2024.131405_bb0170","doi-asserted-by":"crossref","first-page":"13838","DOI":"10.1021\/bi00213a012","article-title":"Crystal structure of d(CGCGAATTCGCG) complexed with propamidine, a short-chain homologue of the drug pentamidine","volume":"32","author":"Nunn","year":"1993","journal-title":"Biochemistry"},{"issue":"15","key":"10.1016\/j.ijbiomac.2024.131405_bb0175","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1016\/j.bmc.2015.06.012","article-title":"Pentamidine analogs as inhibitors of [(3)H]MK-801 and [(3)H]ifenprodil binding to rat brain NMDA receptors","volume":"23","author":"Berger","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2024.131405_bb0180","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0960-894X(00)80302-9","article-title":"Pentamidine congeners 1: synthesis of cis- and trans-butamidine analogues as anti-pneumocystis carinii pneumonia agents","volume":"3","author":"Donkor","year":"1993","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ijbiomac.2024.131405_bb0185","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejmech.2011.12.010","article-title":"Analogs of pentamidine as potential anti-Pneumocystis chemotherapeutics","volume":"48","author":"Maciejewska","year":"2012","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.131405_bb0190","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1039\/C7MD00445A","article-title":"Development of highly active anti-Pneumocystis bisbenzamidines: insight into the influence of selected substituents on the in vitro activity","volume":"8","author":"Maciejewska","year":"2017","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ijbiomac.2024.131405_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105779","article-title":"Deposition of pentamidine analogues in the human body - spectroscopic and computational approaches","volume":"161","author":"Zolek","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2024.131405_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2019.117457","article-title":"Understanding the interaction between alpha-1-acid glycoprotein (AGP) and potential Cu\/Zn metallo-drugs of benzimidazole derived organic motifs: a multi-spectroscopic and molecular docking study","volume":"225","author":"AlAjmi","year":"2020","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.131405_bb0205","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.bbagen.2007.01.009","article-title":"The drug binding site of human alpha1-acid glycoprotein: insight from induced circular dichroism and electronic absorption spectra","volume":"1770","author":"Zsila","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijbiomac.2024.131405_bb0210","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0003-2670(01)80616-4","article-title":"A study of some problems in determining the stoicheiometric proton dissociation constants of complexes by potentiometric titrations using a glass electrode","volume":"38","author":"Irving","year":"1967","journal-title":"Anal. Chim. Acta"},{"year":"1993","series-title":"The IUPAC Stability Constants Database, Academic Software, Version 5.5","author":"SCQuery","key":"10.1016\/j.ijbiomac.2024.131405_bb0215"},{"issue":"10","key":"10.1016\/j.ijbiomac.2024.131405_bb0220","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/0039-9140(96)01958-3","article-title":"Investigation of equilibria in solution. Determination of equilibrium constants with the HYPERQUAD suite of programs","volume":"43","author":"Gans","year":"1996","journal-title":"Talanta"},{"issue":"23","key":"10.1016\/j.ijbiomac.2024.131405_bb0225","doi-asserted-by":"crossref","first-page":"8218","DOI":"10.1039\/D1DT00808K","article-title":"Half-sandwich organometallic Ru and Rh complexes of (N,N) donor compounds: effect of ligand methylation on solution speciation and anticancer activity","volume":"50","author":"Meszaros","year":"2021","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ijbiomac.2024.131405_bb0230","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jinorgbio.2014.01.020","article-title":"Antitumor pentamethylcyclopentadienyl rhodium complexes of maltol and allomaltol: synthesis, solution speciation and bioactivity","volume":"134","author":"Domotor","year":"2014","journal-title":"J. Inorg. Biochem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.131405_bb0235","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jpba.2010.12.025","article-title":"Lipophilicity of kinetically labile metal complexes through the example of antidiabetic Zn(II) and VO(IV) compounds","volume":"54","author":"Enyedy","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131405_bb0240","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00775-012-0944-6","article-title":"Characterization of the binding sites of the anticancer ruthenium(III) complexes KP1019 and KP1339 on human serum albumin via competition studies","volume":"18","author":"Domotor","year":"2013","journal-title":"J. Biol. Inorg. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131405_bb0245","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s00775-014-1211-9","article-title":"Interaction of the anticancer gallium(III) complexes of 8-hydroxyquinoline and maltol with human serum proteins","volume":"20","author":"Enyedy","year":"2015","journal-title":"J. Biol. Inorg. Chem."},{"year":"2006","series-title":"Principles of Fluorescence Spectroscopy","author":"Lakowicz","key":"10.1016\/j.ijbiomac.2024.131405_bb0250"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131405_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032849","article-title":"Evaluation of in vitro distribution and plasma protein binding of selected antiviral drugs (Favipiravir, Molnupiravir and Imatinib) against SARS-CoV-2","volume":"24","author":"Domotor","year":"2023","journal-title":"Int. J. Mol. Sci."},{"year":"2021","series-title":"Discovery Studio, [Version 21]","author":"D.S. BIOVIA","key":"10.1016\/j.ijbiomac.2024.131405_bb0260"},{"year":"2016","series-title":"Gaussian 16","author":"Frisch","key":"10.1016\/j.ijbiomac.2024.131405_bb0265"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131405_bb0270","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jcc.540110311","article-title":"Determining atom-centered monopoles from molecular electrostatic potentials - the need for high sampling density in Formamide conformational-analysis","volume":"11","author":"Breneman","year":"1990","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ijbiomac.2024.131405_bb0275","unstructured":"I. ADMET Predictor v. 10.4.05. Lancaster: Simulations Plus."},{"issue":"2","key":"10.1016\/j.ijbiomac.2024.131405_bb0280","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jcc.540040211","article-title":"Charmm - a program for macromolecular energy, minimization, and dynamics calculations","volume":"4","author":"Brooks","year":"1983","journal-title":"J. Comput. Chem."},{"issue":"5","key":"10.1016\/j.ijbiomac.2024.131405_bb0285","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.3390\/molecules19056609","article-title":"In silico docking, molecular dynamics and binding energy insights into the bolinaquinone-clathrin terminal domain binding site","volume":"19","author":"Abdel-Hamid","year":"2014","journal-title":"Molecules"},{"issue":"12","key":"10.1016\/j.ijbiomac.2024.131405_bb0290","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/ar000033j","article-title":"Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models","volume":"33","author":"Kollman","year":"2000","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ijbiomac.2024.131405_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.917968","article-title":"Phenotypic screening of low molecular weight compounds is rich ground for repurposed, on-target drugs","volume":"13","author":"Lipinski","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"24","key":"10.1016\/j.ijbiomac.2024.131405_bb0300","doi-asserted-by":"crossref","first-page":"7738","DOI":"10.1016\/j.bmc.2007.08.060","article-title":"Hologram QSAR model for the prediction of human oral bioavailability","volume":"15","author":"Moda","year":"2007","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2024.131405_bb0305","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00003088-200342010-00003","article-title":"Role of P-glycoprotein in pharmacokinetics: clinical implications","volume":"42","author":"Lin","year":"2003","journal-title":"Clin. Pharmacokinet."},{"issue":"7","key":"10.1016\/j.ijbiomac.2024.131405_bb0310","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4155\/tde.15.34","article-title":"Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrier","volume":"6","author":"Villa","year":"2015","journal-title":"Ther. Deliv."},{"issue":"4","key":"10.1016\/j.ijbiomac.2024.131405_bb0315","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1517\/17425241003610633","article-title":"Drug delivery by red blood cells: vascular carriers designed by mother nature","volume":"7","author":"Muzykantov","year":"2010","journal-title":"Expert Opin. Drug Deliv."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131405_bb0320","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12030276","article-title":"Erythrocytes as carriers: from drug delivery to biosensors","volume":"12","author":"Koleva","year":"2020","journal-title":"Pharmaceutics"},{"year":"2010","series-title":"An Introduction to Organic, Inorganic & Physical Chemistry","author":"Housecroft","key":"10.1016\/j.ijbiomac.2024.131405_bb0325"},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131405_bb0330","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1042\/bj2320863","article-title":"Fluorescence quenching of human orosomucoid. Accessibility to drugs and small quenching agents","volume":"232","author":"Friedman","year":"1985","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.ijbiomac.2024.131405_bb0335","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.2042-7158.1982.tb04212.x","article-title":"Optical studies on the specific interaction of dipyridamole with alpha 1-acid glycoprotein (orosomucoid)","volume":"34","author":"El-Gamel","year":"1982","journal-title":"J. Pharm. Pharmacol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024022104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813024022104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T06:52:55Z","timestamp":1714373575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813024022104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":67,"alternative-id":["S0141813024022104"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131405","relation":{},"ISSN":["0141-8130"],"issn-type":[{"type":"print","value":"0141-8130"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Binding mechanism of pentamidine derivatives with human serum acute phase protein \u03b11-acid glycoprotein","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.131405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"131405"}}